Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107873379 | 10787337 | 9 | F | 201501 | 20160719 | 20150211 | 20160726 | EXP | CA-ROCHE-1534329 | ROCHE | 65.36 | YR | F | Y | 0.00000 | 20160726 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107873379 | 10787337 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 150 MG, EVERY 4 WEEKS | U | S0066B,S0062,S0002F | 103976 | 150 | MG | SOLUTION FOR INJECTION | |||||
| 107873379 | 10787337 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0066B,S0062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 107873379 | 10787337 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0066B,S0062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 107873379 | 10787337 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0062,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 107873379 | 10787337 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0062,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 107873379 | 10787337 | 6 | C | ZENHALE | FORMOTEROL FUMARATEMOMETASONE FUROATE | 1 | Unknown | U | 0 | ||||||||||
| 107873379 | 10787337 | 7 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107873379 | 10787337 | 1 | Asthma |
| 107873379 | 10787337 | 6 | Product used for unknown indication |
| 107873379 | 10787337 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107873379 | 10787337 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107873379 | 10787337 | Aphonia | |
| 107873379 | 10787337 | Arthralgia | |
| 107873379 | 10787337 | Bronchial obstruction | |
| 107873379 | 10787337 | Cough | |
| 107873379 | 10787337 | Dyspnoea | |
| 107873379 | 10787337 | Ear disorder | |
| 107873379 | 10787337 | Ear pain | |
| 107873379 | 10787337 | Gait disturbance | |
| 107873379 | 10787337 | Hypersensitivity | |
| 107873379 | 10787337 | Malaise | |
| 107873379 | 10787337 | Nasal congestion | |
| 107873379 | 10787337 | Nasopharyngitis | |
| 107873379 | 10787337 | Oropharyngeal pain | |
| 107873379 | 10787337 | Pulmonary congestion | |
| 107873379 | 10787337 | Pyrexia | |
| 107873379 | 10787337 | Respiratory tract congestion | |
| 107873379 | 10787337 | Respiratory tract infection | |
| 107873379 | 10787337 | Stress | |
| 107873379 | 10787337 | Toothache | |
| 107873379 | 10787337 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107873379 | 10787337 | 1 | 20130225 | 0 | ||
| 107873379 | 10787337 | 2 | 20150616 | 0 | ||
| 107873379 | 10787337 | 3 | 20160426 | 0 | ||
| 107873379 | 10787337 | 4 | 20160309 | 0 | ||
| 107873379 | 10787337 | 5 | 20160621 | 0 |